Filing Details

Accession Number:
0001179110-21-000066
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-04 17:32:54
Reporting Period:
2020-12-31
Accepted Time:
2021-01-04 17:32:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc. IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1177854 G David Foster 22 Hillside Dr.
Townsend MA 01469
V.p.-Fin., Prin. Acctg. Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-31 27,240 $0.00 48,964 No 4 M Direct
Common Stock Disposition 2020-12-31 11,052 $6.38 37,912 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Share Unit Disposition 2020-12-31 27,240 $0.00 27,240 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  2. On April 1, 2019, the reporting person was granted 45,400 restricted share units, vesting 40% on April 1, 2020 and 60% on December 31, 2020, subject to continued service through each such vesting date.
  3. Restricted stock units convert into common stock on a one-for-one basis
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
  5. Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSU's listed in Table II per a 10b5-1 plan.